Robust arm and leg muscle adaptation to training despite ACE inhibition: a randomized placebo-controlled trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Robust arm and leg muscle adaptation to training despite ACE inhibition: a randomized placebo-controlled trial. / Sjúrðarson, Tórur; Bejder, Jacob; Breenfeldt Andersen, Andreas; Bonne, Thomas Christian; Kyhl, Kasper; Thomassen, Martin; Prats, Júlia; Oddmarsdóttir Gregersen, Noomi; Skoradal, May-Britt; Weihe, Pál; Nordsborg, Nikolai Baastrup; Mohr, Magni.

I: European Journal of Applied Physiology, Bind 123, Nr. 2, 2023, s. 325-337.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Sjúrðarson, T, Bejder, J, Breenfeldt Andersen, A, Bonne, TC, Kyhl, K, Thomassen, M, Prats, J, Oddmarsdóttir Gregersen, N, Skoradal, M-B, Weihe, P, Nordsborg, NB & Mohr, M 2023, 'Robust arm and leg muscle adaptation to training despite ACE inhibition: a randomized placebo-controlled trial', European Journal of Applied Physiology, bind 123, nr. 2, s. 325-337. https://doi.org/10.1007/s00421-022-05072-5

APA

Sjúrðarson, T., Bejder, J., Breenfeldt Andersen, A., Bonne, T. C., Kyhl, K., Thomassen, M., Prats, J., Oddmarsdóttir Gregersen, N., Skoradal, M-B., Weihe, P., Nordsborg, N. B., & Mohr, M. (2023). Robust arm and leg muscle adaptation to training despite ACE inhibition: a randomized placebo-controlled trial. European Journal of Applied Physiology, 123(2), 325-337. https://doi.org/10.1007/s00421-022-05072-5

Vancouver

Sjúrðarson T, Bejder J, Breenfeldt Andersen A, Bonne TC, Kyhl K, Thomassen M o.a. Robust arm and leg muscle adaptation to training despite ACE inhibition: a randomized placebo-controlled trial. European Journal of Applied Physiology. 2023;123(2):325-337. https://doi.org/10.1007/s00421-022-05072-5

Author

Sjúrðarson, Tórur ; Bejder, Jacob ; Breenfeldt Andersen, Andreas ; Bonne, Thomas Christian ; Kyhl, Kasper ; Thomassen, Martin ; Prats, Júlia ; Oddmarsdóttir Gregersen, Noomi ; Skoradal, May-Britt ; Weihe, Pál ; Nordsborg, Nikolai Baastrup ; Mohr, Magni. / Robust arm and leg muscle adaptation to training despite ACE inhibition: a randomized placebo-controlled trial. I: European Journal of Applied Physiology. 2023 ; Bind 123, Nr. 2. s. 325-337.

Bibtex

@article{850821289eed439bb38f74fd6dc0f690,
title = "Robust arm and leg muscle adaptation to training despite ACE inhibition: a randomized placebo-controlled trial",
abstract = "Purpose: Angiotensin-converting enzyme (ACE) inhibitor treatment is widely applied, but the fact that plasma ACE activity is a potential determinant of training-induced local muscular adaptability is often neglected. Thus, we investigated the hypothesis that ACE inhibition modulates the response to systematic aerobic exercise training on leg and arm muscular adaptations.Methods: Healthy, untrained, middle-aged participants (40 ± 7 yrs) completed a randomized, double-blinded, placebo-controlled trial. Participants were randomized to placebo (PLA: CaCO3) or ACE inhibitor (ACEi: enalapril) for 8 weeks and completed a supervised, high-intensity exercise training program. Muscular characteristics in the leg and arm were extensively evaluated pre and post-intervention. Results: Forty-eight participants (nACEi = 23, nPLA = 25) completed the trial. Exercise training compliance was above 99%. After training, citrate synthase, 3-hydroxyacyl-CoA dehydrogenase and phosphofructokinase maximal activity were increased in m. vastus lateralis in both groups (all P < 0.05) without statistical differences between them (all time × treatment P > 0.05). In m. deltoideus, citrate synthase maximal activity was upregulated to a greater extent (time × treatment P < 0.05) in PLA (51 [33;69] %) than in ACEi (28 [13;43] %), but the change in 3-hydroxyacyl-CoA dehydrogenase and phosphofructokinase maximal activity was similar between groups. Finally, the training-induced changes in the platelet endothelial cell adhesion molecule-1 protein abundance, a marker of capillary density, were similar in both groups in m. vastus lateralis and m. deltoideus. Conclusion: Eight weeks of high-intensity whole-body exercise training improves markers of skeletal muscle mitochondrial oxidative capacity, glycolytic capacity and angiogenesis, with no overall effect of pharmacological ACE inhibition in healthy adults.",
keywords = "Faculty of Science, Angiotensin-converting enzyme inhibitors, Muscle oxidative capacity, High-intensity interval training, Muscle-specific adaptations, Angiogenesis",
author = "T{\'o}rur Sj{\'u}r{\dh}arson and Jacob Bejder and {Breenfeldt Andersen}, Andreas and Bonne, {Thomas Christian} and Kasper Kyhl and Martin Thomassen and J{\'u}lia Prats and {Oddmarsd{\'o}ttir Gregersen}, Noomi and May-Britt Skoradal and P{\'a}l Weihe and Nordsborg, {Nikolai Baastrup} and Magni Mohr",
note = "{\textcopyright} 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.",
year = "2023",
doi = "10.1007/s00421-022-05072-5",
language = "English",
volume = "123",
pages = "325--337",
journal = "European Journal of Applied Physiology",
issn = "1439-6319",
publisher = "Springer",
number = "2",

}

RIS

TY - JOUR

T1 - Robust arm and leg muscle adaptation to training despite ACE inhibition: a randomized placebo-controlled trial

AU - Sjúrðarson, Tórur

AU - Bejder, Jacob

AU - Breenfeldt Andersen, Andreas

AU - Bonne, Thomas Christian

AU - Kyhl, Kasper

AU - Thomassen, Martin

AU - Prats, Júlia

AU - Oddmarsdóttir Gregersen, Noomi

AU - Skoradal, May-Britt

AU - Weihe, Pál

AU - Nordsborg, Nikolai Baastrup

AU - Mohr, Magni

N1 - © 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

PY - 2023

Y1 - 2023

N2 - Purpose: Angiotensin-converting enzyme (ACE) inhibitor treatment is widely applied, but the fact that plasma ACE activity is a potential determinant of training-induced local muscular adaptability is often neglected. Thus, we investigated the hypothesis that ACE inhibition modulates the response to systematic aerobic exercise training on leg and arm muscular adaptations.Methods: Healthy, untrained, middle-aged participants (40 ± 7 yrs) completed a randomized, double-blinded, placebo-controlled trial. Participants were randomized to placebo (PLA: CaCO3) or ACE inhibitor (ACEi: enalapril) for 8 weeks and completed a supervised, high-intensity exercise training program. Muscular characteristics in the leg and arm were extensively evaluated pre and post-intervention. Results: Forty-eight participants (nACEi = 23, nPLA = 25) completed the trial. Exercise training compliance was above 99%. After training, citrate synthase, 3-hydroxyacyl-CoA dehydrogenase and phosphofructokinase maximal activity were increased in m. vastus lateralis in both groups (all P < 0.05) without statistical differences between them (all time × treatment P > 0.05). In m. deltoideus, citrate synthase maximal activity was upregulated to a greater extent (time × treatment P < 0.05) in PLA (51 [33;69] %) than in ACEi (28 [13;43] %), but the change in 3-hydroxyacyl-CoA dehydrogenase and phosphofructokinase maximal activity was similar between groups. Finally, the training-induced changes in the platelet endothelial cell adhesion molecule-1 protein abundance, a marker of capillary density, were similar in both groups in m. vastus lateralis and m. deltoideus. Conclusion: Eight weeks of high-intensity whole-body exercise training improves markers of skeletal muscle mitochondrial oxidative capacity, glycolytic capacity and angiogenesis, with no overall effect of pharmacological ACE inhibition in healthy adults.

AB - Purpose: Angiotensin-converting enzyme (ACE) inhibitor treatment is widely applied, but the fact that plasma ACE activity is a potential determinant of training-induced local muscular adaptability is often neglected. Thus, we investigated the hypothesis that ACE inhibition modulates the response to systematic aerobic exercise training on leg and arm muscular adaptations.Methods: Healthy, untrained, middle-aged participants (40 ± 7 yrs) completed a randomized, double-blinded, placebo-controlled trial. Participants were randomized to placebo (PLA: CaCO3) or ACE inhibitor (ACEi: enalapril) for 8 weeks and completed a supervised, high-intensity exercise training program. Muscular characteristics in the leg and arm were extensively evaluated pre and post-intervention. Results: Forty-eight participants (nACEi = 23, nPLA = 25) completed the trial. Exercise training compliance was above 99%. After training, citrate synthase, 3-hydroxyacyl-CoA dehydrogenase and phosphofructokinase maximal activity were increased in m. vastus lateralis in both groups (all P < 0.05) without statistical differences between them (all time × treatment P > 0.05). In m. deltoideus, citrate synthase maximal activity was upregulated to a greater extent (time × treatment P < 0.05) in PLA (51 [33;69] %) than in ACEi (28 [13;43] %), but the change in 3-hydroxyacyl-CoA dehydrogenase and phosphofructokinase maximal activity was similar between groups. Finally, the training-induced changes in the platelet endothelial cell adhesion molecule-1 protein abundance, a marker of capillary density, were similar in both groups in m. vastus lateralis and m. deltoideus. Conclusion: Eight weeks of high-intensity whole-body exercise training improves markers of skeletal muscle mitochondrial oxidative capacity, glycolytic capacity and angiogenesis, with no overall effect of pharmacological ACE inhibition in healthy adults.

KW - Faculty of Science

KW - Angiotensin-converting enzyme inhibitors

KW - Muscle oxidative capacity

KW - High-intensity interval training

KW - Muscle-specific adaptations

KW - Angiogenesis

U2 - 10.1007/s00421-022-05072-5

DO - 10.1007/s00421-022-05072-5

M3 - Journal article

C2 - 36271942

VL - 123

SP - 325

EP - 337

JO - European Journal of Applied Physiology

JF - European Journal of Applied Physiology

SN - 1439-6319

IS - 2

ER -

ID: 323614448